Aandelen in “Biotechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
20/05 | 5,620 USD
-1,06% |
-1,06% |
|
Cabaletta Bio Inc |
20/05 | 12,880 USD
+4,29% |
+4,29% |
|
Calithera Biosciences Inc |
20/05 | 0,020 USD
0,00% |
0,00% |
|
Can-Fite Biopharma Ltd |
20/05 | 2,465 USD
+3,57% |
+3,57% |
|
Capricor Therapeutics Inc |
20/05 | 6,300 USD
+1,61% |
+1,61% |
|
Cara Therapeutics Inc |
20/05 | 0,750 USD
0,00% |
0,00% |
Carbios |
20/05 | 23,000 EUR
+0,44% |
+0,44% |
|
Carisma Therapeutics, Inc. |
20/05 | 1,410 USD
0,00% |
0,00% |
|
CASI Pharmaceuticals Inc |
20/05 | 3,130 USD
-5,15% |
-5,15% |
|
Catalyst Biosciences Inc |
30/10 | 0,511 USD
-2,65% |
-2,65% |
Ceapro Inc. |
17/05 | 0,270 CAD
-6,90% |
-6,90% |
|
Cel-Sci Corp. |
20/05 | 1,260 USD
-0,79% |
-0,79% |
|
Celldex Therapeutics Inc. |
20/05 | 37,750 USD
-1,20% |
-1,20% |
|
Cellectar Biosciences Inc |
20/05 | 3,160 USD
-4,24% |
-4,24% |
|
Cellectis |
20/05 | 2,660 EUR
+0,57% |
+0,57% |
|
Cellectis |
20/05 | 2,970 USD
-0,67% |
-0,67% |
|
Celyad Oncology |
20/07 | 0,524 USD
-5,42% |
-5,42% |
Celyad Oncology |
20/05 | 0,318 EUR
+1,44% |
+1,44% |
|
Champions Oncology Inc |
20/05 | 4,760 USD
+1,28% |
+1,28% |
|
Chimerix Inc |
20/05 | 0,986 USD
-0,18% |
-0,18% |
|
Chinook Therapeutics Inc |
10/08 | 40,390 USD
+0,22% |
+0,22% |
|
Cidara Therapeutics Inc |
20/05 | 11,260 USD
+0,45% |
+0,45% |
|
Clovis Oncology Inc |
21/02 | 0,090 USD
+18,42% |
+18,42% |
|
Co-Diagnostics Inc |
20/05 | 1,100 USD
+0,92% |
+0,92% |
|
Cogent Biosciences Inc |
20/05 | 7,840 USD
+5,38% |
+5,38% |
|
CohBar Inc |
20/05 | 1,000 USD
+13,62% |
+13,62% |
|
Coherus Biosciences Inc |
20/05 | 2,080 USD
-1,89% |
-1,89% |
|
CollPlant Biotechnologies Ltd |
20/05 | 6,190 USD
-2,37% |
-2,37% |
|
Compass Pathways Plc |
20/05 | 7,920 USD
+1,02% |
+1,02% |
|
Compugen Ltd. |
20/05 | 1,740 USD
-17,54% |
-17,54% |
|
Concert Pharmaceuticals Inc |
13/05 | 8,370 USD
0,00% |
0,00% |
|
ContraFect Corp |
6/02 | 0,033 USD
+8,73% |
+8,73% |
|
Corbus Pharmaceuticals Holdings Inc |
20/05 | 48,550 USD
+7,89% |
+7,89% |
|
CRISPR Therapeutics AG |
20/05 | 55,470 USD
-1,33% |
-1,33% |
|
Cue Biopharma Inc |
20/05 | 1,870 USD
+9,36% |
+9,36% |
|
Curis Inc |
20/05 | 10,520 USD
-10,85% |
-10,85% |
|
Cyclacel Pharmaceuticals Inc |
20/05 | 6,990 USD
+14,03% |
+14,03% |
|
Cyclacel Pharmaceuticals Inc |
20/05 | 2,180 USD
-4,80% |
-4,80% |
|
Cymabay Therapeutics Inc |
21/03 | 32,480 USD
+0,03% |
+0,03% |
|
Cytokinetics Inc |
20/05 | 60,600 USD
+1,80% |
+1,80% |
|
CytomX Therapeutics Inc |
20/05 | 1,920 USD
+1,59% |
+1,59% |
Cytotools AG |
20/05 | 0,500 EUR
0,00% |
0,00% |